Back
Cara Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
CARA
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
39
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeCara Therapeutics Price Quote
$0.30
+0.01 (+3.27%)
(Updated: November 5, 2024 at 4:10 PM ET)
Cara Therapeutics Key Stats
Sell
39
Cara Therapeutics (CARA)
is a Sell
Day range:
$0.28 - $0.30
52-week range:
$0.24 - $1.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.44
P/B ratio:
1.37%
Volume:
285.7K
Avg. volume:
404.3K
1-year change:
-78.48%
Market cap:
$15.9M
Revenue:
$21M
EPS:
$-2.04
How Much Does Cara Therapeutics Make?
-
How Much Are Cara Therapeutics's Sales Annually?
CARA Revenues are $21M -
How Much Profit Does Cara Therapeutics's Make A Year?
CARA net income is -$118.5M
Is Cara Therapeutics Growing As A Company?
-
What Is Cara Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.86% -
What Is Cara Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cara Therapeutics Stock Price Performance
-
Did Cara Therapeutics Stock Go Up Last Month?
Cara Therapeutics share price went up by 5.41% last month -
Did CARA's Share Price Rise Over The Last Year?
CARA share price fell by -78.48% over the past 1 year
What Is Cara Therapeutics 52-Week High & Low?
-
What Is Cara Therapeutics’s 52-Week High Share Price?
Cara Therapeutics has traded as high as $1.40 over the past 52 weeks -
What Is Cara Therapeutics’s 52-Week Low Share Price?
Cara Therapeutics has traded as low as $0.24 over the past 52 weeks
Cara Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cara Therapeutics?
-
How Much Debt Does Cara Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Cara Therapeutics Have?
Cash and short term investments quarterly total is $56.6M -
What Is Cara Therapeutics’s Book Value Per Share?
Book value per share is 0.21
Is Cara Therapeutics Cash Flow Positive?
-
What Is CARA Cash Flow From Operations?
Cash flow from operations (TTM) is -$79.9M -
What Is Cara Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $36.3M -
What Is Cara Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $34.2M
Cara Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CARA return on invested capital is -189.52% -
What Is Cara Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -103.2% -
What Is CARA Return On Equity?
ROE is a measure of profitability and is -189.52%
Cara Therapeutics Earnings Date & Stock Price
-
What Is Cara Therapeutics's Stock Price Today?
A single share of CARA can be purchased today for 0.29 -
What Is Cara Therapeutics’s Stock Symbol?
Cara Therapeutics trades on the nasdaq under the ticker symbol: CARA -
When Is Cara Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Cara Therapeutics is scheduled on November 13, 2024 -
When Is CARA's next ex-dividend date?
Cara Therapeutics's next ex-dividend date is May 7, 2020 -
How To Buy Cara Therapeutics Stock?
You can buy Cara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cara Therapeutics Competitors
-
Who Are Cara Therapeutics's Competitors?
Below is a list of companies who compete with Cara Therapeutics or are related in some way:
Cara Therapeutics Dividend Yield
-
What Is CARA Dividend Yield?
Cara Therapeutics’s dividend yield currently is 0% -
What Is Cara Therapeutics’s Payout Ratio?
Cara Therapeutics’s payout ratio is 0% -
When Did Cara Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Cara Therapeutics’s Dividend Per Share?
Cara Therapeutics pays a dividend of $0.00 per share
Cara Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -33% |
Revenue: | -85.71% | -15.56% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 1.66 |
Upside from Last Price: | 469.71% |